No Data
No Data
HKEX Market News: Genscript Bio (01548) rises over 3%. CAR-T therapy Q2 net sales were approximately 0.186 billion US dollars.
Genscript Bio (01548) rose more than 3%. As of press time, it increased by 3.28% to HKD 13.84 with a turnover of HKD 81.1735 million.
Genscript Bio: CARVYKTI's net sales in the second quarter of the year is approximately 0.186 billion USD.
Genscript Bio (01548) announced that Legend Biotech Co., Ltd. (Legend Biotech), a non-wholly-owned subsidiary of the company whose shares are listed on the NASDAQ Global Select Market in the United States, in the form of American depositary shares.
Hong Kong stocks saw unusual activity as CRO concept stocks rose collectively. With the nearing interest rate cut by the Federal Reserve and frequent bullish policies, the sector is expected to usher in marginal improvements.
Concept stocks of CRO have collectively risen. As of press time, Tigermed (03347) rose 4.75%, to HKD 28.65; Genscript Bio (01548) rose 4.66%, to HKD 13.02.
Hong Kong stock market news | Genscript Bio (01548) fell more than 4%, with a total market value of over 25 billion Hong Kong dollars. Reports suggest that Legend Biotech may have received a takeover offer.
Genscript Bio (01548) fell more than 4%, and as of press time, it fell by 3.67% to HKD 12.08, with a turnover of 0.168 billion HKD, and a total market value exceeding 25 billion HKD.
Hong Kong stock market closed on 07/15, with the Hang Seng Index falling by 1.52%. Network technology stocks were generally under pressure, while digital currency ETFs and golden industrial concept stocks rose against the trend.
Hong Kong's three major indexes fluctuated down all day, with the Hengkang index falling more than 3% in the afternoon and the Hang Seng Index barely holding onto the 18,000 level. At the close, the Hang Seng index fell 1.52% or 277.44 points to 18015.94 points.
Genscript Bio (01548): Unusual fluctuations in stock price and volume, reasons unknown.
Genscript Bio (01548) has released an announcement, and the board of directors of the company has noticed that the company's stock price and volume have recently...
No Data